Idat.i
Merge
Accueil
Racine
Merge
Exploration
Accueil
Racine
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Merge (Accueil)

Index « Idat.i » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : Idat.i

Pour accéder à une entrée :

Les termes de plus forte occurence

40317-1671:2013:Akram S:parkinson:s:disease
40091-2700:2001:Doudet D:monitoring:disease:progression
40090-3019:1991:Parkinson D:to:the:editor
40028-4793:1998:Lang A:parkinson:s:disease
31388-2457:2001:Chen R:impairment:of:motor
31388-2457:2001:Ashby P:potentials:recorded:at
31355-6037:1998:Jaeggi E:ventriculo:atrial:time
31172-7047:2007:Mcgeer E:the:role:of
30936-3076:1994:Hammerstad J:tendon:jerks:in
30887-4476:2008:Seeman P:dopamine:d:high
30885-3185:2002:Rajput A:clinical:pathological:study
30885-3185:2002:Lang A:deep:brain:stimulation
30885-3185:2002:Kim Y:combination:of:dopamine
30885-3185:2001:Marras C:year:old:man
30885-3185:2000:Dromey C:an:investigation:of
30364-5134:2000:Lee C:in:vivo:positron
30361-9230:1991:Jolicoeur F:hypokinesia:rigidity:and
30306-3623:1994:Yu P:pharmacological:and:clinical
30304-3940:1996:Yasuhara O:midkine:like:immunoreactivity
30304-3940:1989:Bedard P:effect:of:d
30300-8177:1992:Kalra J:serum:antioxidant:enzyme
30278-5846:1995:Gagnon C:effect:of:adding
30278-5846:1988:Pisa M:regional:specialization:of
30278-5846:1988:Hassan M:dopamine:receptors:in
30278-2626:1997:Doyon J:role:of:the
30278-2626:1990:Taylor A:memory:and:learning
30271-3586:1990:Hertzman C:parkinson:s:disease
30166-4328:2000:De La Fuente Fernandez R:nigrostriatal:dopamine:system
30166-4328:1997:Whishaw I:impairments:and:compensation
30165-6147:1997:Anderson C:potential:signalling:roles
30165-0270:1999:Norman K:the:measurement:of
30165-0270:1994:Beuter A:the:measurement:of
30162-0134:1989:Karlik S:polynucleotide:cross:linking
30147-8389:1990:Fromer M:clinical:experience:with
30090-6905:1992:Flint A:acoustic:analysis:in
30090-3019:1998:Tasker R:deep:brain:stimulation
30035-8711:2011:Blake C:the:wigglez:dark
30028-3908:1991:Rivest R:structure:activity:studies
30022-510X:1988:Perry T:phenylpyridine:and:phenylpyridine
30022-3050:1989:Riley D:frozen:shoulder:and
30022-3050:1989:Calne D:is:parkinson:s
30014-4886:1992:Gomez Mancilla B:effect:of:chronic
30014-2999:1990:Rouillard C:effects:of:chronic
30007-0769:1993:Lemery R:results:of:a
30006-8993:1998:Walker D:immunohistochemical:analyses:of
30006-8993:1998:Walker D:expression:of:the
30006-8993:1996:Schwab C:neurofibrillary:tangles:of
30006-8993:1996:Martens D:spatio:temporal:impairments
30006-8993:1995:Miklyaeva E:impairments:and:compensatory
30006-8993:1995:Calon F:levodopa:or:d
30006-8993:1994:Tooyama I:retention:of:basic
30006-8993:1994:Shannak K:noradrenaline:dopamine:and
30006-8993:1988:Rogers M:motor:planning:is
30006-8993:1988:Filion M:abnormal:influences:of
30006-8950:2000:Saint Cyr J:neuropsychological:consequences:of
30006-8950:2000:Pahapill P:the:pedunculopontine:nucleus
30006-8950:2000:Lee C:embryonic:ventral:mesencephalic
30006-8950:1999:Samii A:reassessment:of:unilateral
30006-8950:1999:Gross R:relationship:of:lesion
30006-8950:1988:Saint Cyr J:procedural:learning:and
30002-9262:1995:Semchuk K:effects:of:agricultural
30002-9149:1994:Thakur R:embolic:complications:after
30002-9149:1994:Lemery R:catheter:ablation:using
30002-9149:1993:Stites H:evaluation:of:an
30002-9149:1991:Murdock C:epicardial:mapping:in
30002-9149:1991:Leather R:radiofrequency:catheter:ablation
30002-9149:1990:Zardini M:atrioventricular:nodal:reentry
30002-9149:1990:Boahene K:value:of:a
30002-9149:1989:Szabo T:usefulness:of:isoproterenol
30002-9149:1988:Guiraudon G:the:coronary:sinus
30002-8703:1993:Wathen M:initiation:of:atrial
30002-8703:1993:Jones D:biphasic:versus:sequential
30002-8703:1991:Giorgi C:body:surface:potential
30002-8703:1989:Dubuc M:electrophysiologic:effects:of
30001-6322:1996:Schwab C:distinct:distribution:of
30001-6322:1995:Schwab C:relationship:of:amyloid
30001-6322:1992:Lach B:caudate:nucleus:pathology
28756-7938:2008:Baghbaderani B:expansion:of:human
28756-3282:2012:Dennison E:effect:of:co
21748-6645:2013:Davidson P:source:memory:in
21748-6645:2013:Christopher L:neuroimaging:of:brain
21615-9306:2005:Wady L:methyl:benzoate:as
21552-4825:2009:Zaleski C:the:co:occurrence
21543-3633:2005:Perretta J:effects:of:parkinson
21530-7026:2003:Pell M:processing:emotional:tone
21471-003X:2011:Neuwelt E:engaging:neuroscience:to
21420-8008:2005:Wiltshire K:corpus:callosum:in
21388-2457:2007:Stemmer B:the:error:negativity
21388-2457:2007:Fawcett A:saccade:related:potentials
21388-2457:2005:Duval C:the:impact:of
21388-2457:2004:Hanajima R:somatosensory:evoked:potentials
21388-2457:2003:Wennberg R:intracranial:volume:conduction
21388-2457:2002:Tremblay F:cortico:motor:excitability
21381-6128:2005:Hayley S:multiple:mechanisms:of
21381-6128:2000:Cyr M:drugs:with:estrogen
21380-3395:2006:Burton C:intraindividual:variability:as
21380-3395:2002:Kingstone A:orienting:attention:in
21368-5031:2008:Poewe W:diagnosis:and:management
21359-6446:1998:Samii A:prospects:for:new
21353-8020:2001:Rajput A:levodopa:prolongs:life
21353-8020:2001:Pal P:positron:emission:tomography
21353-8020:1996:Calne S:validating:a:quality
21352-4585:2003:Mcdonnell G:clinical:presentation:of
21351-0711:2013:Harris M:head:injuries:and
21170-7690:2006:Willan A:economic:evaluation:of
21170-7690:2003:Iskedjian M:cost:analysis:of
21079-5006:1999:Mitnitski A:the:rate:of
21065-9471:2010:Ng B:focusing:effects:of
21065-9471:2009:Ballanger B:cerebral:blood:flow
21059-910X:2010:Hermo L:surfing:the:wave
21045-3873:2000:Barlow M:unipolar:electrogram:characteristics
21045-3873:1994:Li H:fatigue:phenomenon:in
21041-6102:2006:Vida S:an:month:prospective
21041-6102:2005:Hagen B:antipsychotic:drug:use
21034-4810:1991:Rosenberg H:near:miss:sudden
21021-7762:1998:Le Dorze G:a:comparison:of
21011-6125:2016:Hamani C:pedunculopontine:nucleus:region
21011-6125:2002:Westerberg B:the:effects:of
21011-6125:1998:Lozano A:microelectrode:recordings:define
21011-6125:1998:Ashby P:immediate:motor:effects
21010-7940:1988:Guiraudon G:surgical:approach:to
20964-6906:2011:Ross O:ataxin:repeat:length
20964-6906:2010:Kanao T:activation:of:foxo
20964-6906:2010:Irrcher I:loss:of:the
20964-6906:2009:Venderova K:leucine:rich:repeat
20964-6906:2009:Cronin K:expansion:of:the
20962-1083:2000:Mccusker M:mitochondrial:dna:variation
20960-0760:2003:Bhavnani B:estrogens:and:menopause
20959-4965:2011:Weinberger M:a:basis:for
20959-4965:2004:Frak V:a:dissociation:between
20959-4965:2003:Strafella A:subthalamic:deep:brain
20959-4965:1997:Newman D:a:kappa:opioid
20959-4965:1995:Chagnon P:distribution:of:brain
20959-4965:1994:Hutchison W:differential:neuronal:activity
20959-4965:1994:Figlewicz D:the:cu:zn
20959-4965:1994:Asselin M:striatal:changes:in
20959-4388:1998:Lozano A:new:developments:in
20953-8194:2012:Al Sweidi S:oestrogen:receptors:and
20953-816X:2013:Sutton A:elevated:potassium:provides
20953-816X:2013:Huot P:use:of:catechol
20953-816X:2001:Metz G:chronic:levodopa:therapy
20929-1393:1998:Mclean M:impacts:of:the
20926-6410:2005:Pell M:facial:expression:decoding
20920-9964:2005:Chouinard G:manual:for:the
20895-4356:2003:Coyle D:measures:of:importance
20895-4356:1994:Wang F:reliability:of:environmental
20895-4356:1994:Fu Lin Wang:reliability:of:environmental
20895-4356:1992:Wang F:an:assessment:of
20894-878X:1997:Freedman M:breakdown:of:cross
20894-4105:2013:Foster E:prospective:memory:in
20894-4105:2005:Gilbert B:study:of:verbal
20894-4105:1998:West R:the:contribution:of
20894-1491:2005:Klegeris A:chymotrypsin:like:proteases
20893-6080:2000:Monchi O:a:neural:model
20893-0341:1998:Mcgeer P:glial:cell:reactions
20891-9887:2012:Matteau E:clinical:validity:of
20891-9887:1997:Mamelak M:neurodegeneration:sleep:and
20891-9887:1993:Rajput A:alzheimer:s:disease
20891-5849:1999:Ste Marie L:local:striatal:infusion
20890-6238:1991:Levy M:fetal:outcome:following
20887-8994:1994:Sloane A:neuronal:intranuclear:hyaline
20887-6177:2008:Fraraccio M:absence:of:cognitive
20885-6230:2007:Voon V:antidepressants:and:psychosis
20885-3185:2012:Vendette M:brain:perfusion:anomalies
20885-3185:2012:Stern M:toward:a:redefinition
20885-3185:2012:Siderowf A:premotor:parkinson:s
20885-3185:2012:Romenets S:rapid:eye:movement
20885-3185:2012:Reginold W:the:pill:questionnaire
20885-3185:2012:Ray N:the:neurobiology:and
20885-3185:2012:Ravina B:dopamine:transporter:imaging
20885-3185:2012:Postuma R:rapid:eye:movement
20885-3185:2012:Postuma R:identifying:prodromal:parkinson
20885-3185:2012:Pifl C:thalamic:noradrenaline:in
20885-3185:2012:Lees A:perampanel:an:ampa
20885-3185:2012:Huot P:increased:levels:of
20885-3185:2012:Harris M:association:of:parkinson
20885-3185:2012:Goldman S:genetic:modification:of
20885-3185:2012:Godau J:neuroimaging:current:role
20885-3185:2012:Fox S:a:critique:of
20885-3185:2012:Dubois B:donepezil:in:parkinson
20885-3185:2012:De Cock V:suggested:immobilization:test
20885-3185:2012:Buchman A:locus:coeruleus:neuron
20885-3185:2012:Bertrand J:color:discrimination:deficits
20885-3185:2011:Vendette M:brain:perfusion:and
20885-3185:2011:Van Lieshout P:tongue:control:for
20885-3185:2011:Stoessl A:milestones:in:neuroimaging
20885-3185:2011:Seppi K:the:movement:disorder
20885-3185:2011:Sampaio C:pardoprunox:in:early
20885-3185:2011:Ross O:genetic:variants:of
20885-3185:2011:Rascol O:milestones:in:parkinson
20885-3185:2011:Postuma R:cardiac:autonomic:denervation
20885-3185:2011:Ponce F:the:most:cited
20885-3185:2011:Marras C:predictors:of:time
20885-3185:2011:Lang A:a:critical:appraisal
20885-3185:2011:Kupsch A:early:postoperative:management
20885-3185:2011:Koprich J:the:selective:mu
20885-3185:2011:Klein C:the:curious:case
20885-3185:2011:Kimmelman J:risk:of:surgical
20885-3185:2011:Heldman D:the:modified:bradykinesia
20885-3185:2011:Goldman J:racial:differences:may
20885-3185:2011:Fox S:the:movement:disorder
20885-3185:2011:Espay A:differential:response:of
20885-3185:2011:Cilia R:pathological:gambling:in
20885-3185:2011:Camicioli R:ventricular:dilatation:and
20885-3185:2011:Berg D:afq:treatment:of
20885-3185:2011:Altman R:caffeine:in:parkinson
20885-3185:2010:Yeh I:somatosensory:evoked:potentials
20885-3185:2010:Vitek J:standard:guidelines:for
20885-3185:2010:Sossi V:dopamine:turnover:increases
20885-3185:2010:Sage M:a:positive:influence
20885-3185:2010:Roland K:an:exploration:of
20885-3185:2010:Postuma R:cardiac:autonomic:dysfunction
20885-3185:2010:Okun M:reply:based:on
20885-3185:2010:Moro E:long:term:results
20885-3185:2010:Lozano A:basal:ganglia:physiology
20885-3185:2010:Lim S:the:nonmotor:symptoms
20885-3185:2010:Johnston T:effect:of:histamine
20885-3185:2010:Gagnon J:the:montreal:cognitive
20885-3185:2010:Evans A:compulsive:use:of
20885-3185:2010:Espay A:early:versus:delayed
20885-3185:2010:Elble R:impact:of:belief
20885-3185:2010:Colosimo C:task:force:report
20885-3185:2010:Chou K:a:recommended:scale
20885-3185:2010:Callaghan R:incidence:of:parkinson
20885-3185:2010:Bronzova J:double:blind:study
20885-3185:2009:Wider C:fgf:and:parkinson
20885-3185:2009:Weintraub D:validation:of:the
20885-3185:2009:Volkmann J:long:term:effects
20885-3185:2009:Van Nuenen B:mapping:preclinical:compensation
20885-3185:2009:Sage M:symptom:and:gait
20885-3185:2009:Ravina B:the:course:of
20885-3185:2009:Ravina B:a:longitudinal:program
20885-3185:2009:Rajput A:alpha:synuclein:polymorphisms
20885-3185:2009:Postuma R:idiopathic:rem:sleep
20885-3185:2009:Marras C:a:comparison:of
20885-3185:2009:Louis E:torpedoes:in:parkinson
20885-3185:2009:Klein C:hereditary:parkinsonism:parkinson
20885-3185:2009:Hauser R:double:blind:trial
20885-3185:2009:Fox S:serotonin:and:parkinson
20885-3185:2009:Evans A:impulsive:and:compulsive
20885-3185:2009:Elahi B:effect:of:transcranial
20885-3185:2009:Djarmati A:atp:a:variants
20885-3185:2009:Cobb S:gch:in:early
20885-3185:2009:Camicioli R:homocysteine:is:not
20885-3185:2008:Toth C:neuropathy:as:a
20885-3185:2008:Postuma R:manifestations:of:parkinson
20885-3185:2008:Olanow C:a:randomized:double
20885-3185:2008:Oates A:control:of:dynamic
20885-3185:2008:Munhoz R:the:g:s
20885-3185:2008:Mcnicoll C:huntington:cag:repeat
20885-3185:2008:Mcgeer P:glial:reactions:in
20885-3185:2008:Martin W:intact:presupplementary:motor
20885-3185:2008:Marras C:predictors:of:deterioration
20885-3185:2008:Lim S:do:dyskinesia:and
20885-3185:2008:Goetz C:movement:disorder:society
20885-3185:2008:Fox S:levodopa:related:motor
20885-3185:2008:Boileau I:elevated:serotonin:transporter
20885-3185:2007:Thomsen T:ipratropium:bromide:spray
20885-3185:2007:Strafella A:subdural:motor:cortex
20885-3185:2007:Rektorova I:functional:abnormalities:in
20885-3185:2007:Postuma R:is:there:seasonal
20885-3185:2007:Pickering R:a:meta:analysis
20885-3185:2007:Piboolnurak P:levodopa:response:in
20885-3185:2007:Miyasaki J:punding:prevalence:in
20885-3185:2007:Mendonca D:methylphenidate:improves:fatigue
20885-3185:2007:Marras C:antipsychotic:use:in
20885-3185:2007:Li J:interhemispheric:and:ipsilateral
20885-3185:2007:Landau A:proteasome:inhibitor:model
20885-3185:2007:Kishore A:unilateral:versus:bilateral
20885-3185:2007:Hauser R:ten:year:follow
20885-3185:2007:Hallett P:striatal:delta:opioid
20885-3185:2007:Goetz C:movement:disorder:society
20885-3185:2007:Emre M:clinical:diagnostic:criteria
20885-3185:2007:Djarmati A:rapid:and:reliable
20885-3185:2007:Camicioli R:magnetic:resonance:spectroscopic
20885-3185:2007:Berney A:mood:stability:during
20885-3185:2007:Almeida Q:dopaminergic:modulation:of
20885-3185:2006:Zadikoff C:homozygous:and:heterozygous
20885-3185:2006:Voon V:deep:brain:stimulation
20885-3185:2006:Volkmann J:basic:algorithms:for
20885-3185:2006:Visanji N:pharmacological:characterization:of
20885-3185:2006:Sherer T:crossroads:in:gdnf
20885-3185:2006:Rascol O:development:of:dyskinesias
20885-3185:2006:Morissette M:prevention:of:levodopa
20885-3185:2006:Mercado R:expectation:and:the
20885-3185:2006:Lang A:deep:brain:stimulation
20885-3185:2006:Koochesfahani K:oral:methylphenidate:fails
20885-3185:2006:Grimes D:translated:mutation:in
20885-3185:2006:Gomez Ramirez J:histamine:h:receptor
20885-3185:2006:Fox S:translation:of:nondopaminergic
20885-3185:2006:Deuschl G:deep:brain:stimulation
20885-3185:2006:Ardouin C:pathological:gambling:in
20885-3185:2005:Stacy M:identification:of:motor
20885-3185:2005:Proulx M:salivary:production:in
20885-3185:2005:Postuma R:does:severity:of
20885-3185:2005:Nataraj A:parkinson:s:disease
20885-3185:2005:Lun V:comparison:of:the
20885-3185:2005:Levesque J:gabaergic:interneurons:in
20885-3185:2005:Kishore A:normalization:of:voice
20885-3185:2005:Karamohamed S:absence:of:previously
20885-3185:2005:Camicioli R:apolipoprotein:e:and
20885-3185:2005:Brotchie J:nondopaminergic:mechanisms:in
20885-3185:2004:Toth C:anomalies:of:asymmetry
20885-3185:2004:Pereira L:neuronal:activity:in
20885-3185:2004:Olanow C:levodopa:in:the
20885-3185:2004:Marras C:quality:of:life
20885-3185:2004:Kleiner Fisman G:subthalamic:nucleus:deep
20885-3185:2004:Hedrich K:distribution:type:and
20885-3185:2004:Furtado S:profile:of:families
20885-3185:2003:Stefurak T:deep:brain:stimulation
20885-3185:2003:Inkster L:leg:muscle:strength
20885-3185:2003:Guttman M:burden:of:parkinsonism
20885-3185:2003:Fitzmaurice P:nigral:glutathione:deficiency
20885-3185:2003:Camicioli R:parkinson:s:disease
20885-3185:2003:Calon F:changes:of:gaba
20885-3185:2003:Belanger N:chronic:treatment:with
20885-3185:2003:Adkin A:fear:of:falling
20885-3185:2002:Lozano A:microelectrode:recordings:in
20885-3185:2002:Grimes D:large:french:canadian
20885-3185:2002:Dostrovsky J:mechanisms:of:deep
20885-3185:2002:Almeida Q:bimanual:coordination:deficits
20885-3185:2001:Nieves A:acute:onset:dystonic
20885-3185:2001:Hutton J:transdermal:dopaminergic:d
20885-3185:2000:Tonolli I:lateral:leg:raising
20885-3185:2000:Mohr E:risperidone:in:the
20885-3185:1998:Kumar R:pallidotomy:and:deep
20885-3185:1997:Rajput A:dopa:responsive:nonprogressive
20885-3185:1997:Rajput A:concordance:of:common
20885-3185:1997:Prochazka A:measurement:of:rigidity
20885-3185:1996:Ye F:basal:ganglia:iron
20885-3185:1996:Blanchet P:dyskinesia:and:wearing
20885-3185:1995:Suchowersky O:beneficial:effect:of
20885-3185:1995:Nahmias C:a:probe:for
20885-3185:1995:Lang A:hemiatrophy:juvenile:onset
20885-3185:1994:Mosewich R:pulmonary:embolism:an
20885-3185:1994:Mendis T:symptomatic:relief:from
20885-3185:1994:Hertzman C:a:case:control
20885-3185:1993:Guttman M:administration:of:the
20885-3185:1993:Gomez Mancilla B:effect:of:adding
20885-3185:1992:Pourcher E:ethosuximide:and:tremor
20885-3185:1992:Gomez Mancilla B:effect:of:ly
20885-3185:1992:Gomez Mancilla B:effect:of:ethosuximide
20885-3185:1990:Svenson L:geographic:distribution:of
20832-610X:2000:Robinson J:familial:hypokalemic:periodic
20767-3981:2012:Rascol O:a:proof:of
20767-3981:1995:Blanchet P:is:striatal:dopaminergic
20742-3098:2007:Sharma R:neural:stem:cell
20740-3194:1996:Ye F:estimation:of:brain
20738-3991:1999:Mackenzie G:issues:that:influence
20735-7044:1996:Miklyaeva E:hemiparkinson:analogue:rats
20735-1097:1989:Fujimura O:acute:effect:of
20735-1097:1988:Jones D:sequential:pulse:defibrillation
20735-1097:1987:Milstein S:comparison:of:the
20733-8619:1992:Guttman M:dopamine:receptors:in
20531-5565:2000:Schipper H:heme:oxygenase:role
20531-5565:1998:Mcgeer E:the:importance:of
20364-5134:2012:Marras C:dihydropyridine:calcium:channel
20364-5134:2012:Goldman S:solvent:exposures:and
20364-5134:2012:Goldman S:head:injury:alpha
20364-5134:2011:Voon V:impulse:control:disorders
20364-5134:2011:Cullen V:acid:glucosidase:mutants
20364-5134:2010:Weintraub D:amantadine:use:associated
20364-5134:2010:Toth C:levodopa:methylmalonic:acid
20364-5134:2010:Stocchi F:initiating:levodopa:carbidopa
20364-5134:2010:Rylander D:maladaptive:plasticity:of
20364-5134:2009:Gagnon J:mild:cognitive:impairment
20364-5134:2009:Ballanger B:stimulation:of:the
20364-5134:2008:Wenning G:multiple:system:atrophy
20364-5134:2008:Martin W:dihydrotetrabenazine:positron:emission
20364-5134:2007:Sossi V:dopamine:transporter:relation
20364-5134:2006:Samadi P:docosahexaenoic:acid:reduces
20364-5134:2006:Lang A:randomized:controlled:trial
20364-5134:2006:Galpern W:interface:between:tauopathies
20364-5134:2004:Tong J:brain:dopamine:stimulated
20364-5134:2003:Whone A:slower:progression:of
20364-5134:2003:Olanow C:a:double:blind
20364-5134:2003:Mcgeer P:presence:of:reactive
20364-5134:2003:Hutchison W:pallidal:neuronal:activity
20364-5134:2003:Hague S:early:onset:parkinson
20364-5134:2002:Furukawa Y:brain:proteasomal:function
20364-5134:2001:Fukuda M:functional:correlates:of
20364-5134:2001:De La Fuente Fernandez R:biochemical:variations:in
20364-5134:2000:Lozano A:neuronal:recordings:in
20364-5134:2000:Lang A:surgery:for:levodopa
20364-5134:2000:Huynh D:parkin:is:associated
20364-5134:2000:Filion M:physiologic:basis:of
20364-5134:2000:Calon F:molecular:basis:of
20364-5134:1998:Hutchison W:neurophysiological:identification:of
20364-5134:1997:Vingerhoets F:which:clinical:sign
20364-5134:1994:Vingerhoets F:positron:emission:tomographic
20364-5134:1994:Vingerhoets F:longitudinal:fluorodopa:positron
20364-5134:1994:Uitti R:parkinsonism:induced:by
20364-5134:1993:Snow B:human:positron:emission
20364-5134:1992:Schulzer M:the:antiparkinson:efficacy
20364-5134:1992:Calne D:the:free:radical
20364-5134:1992:Calne D:criteria:for:diagnosing
20364-5134:1991:Bhatt M:positron:emission:tomography
20364-5134:1989:Wolters E:positron:emission:tomography
20364-5134:1989:Rajput A:parkinsonism:and:neurofibrillary
20364-5134:1988:Mcgeer P:rate:of:cell
20364-5134:1988:Gilbert J:dementia:parkinsonism:and
20364-3190:1996:Berry M:aromatic:l:amino
20364-3190:1994:Scarr E:the:effects:of
20363-6135:2006:Dolinsky V:role:of:amp
20362-5664:1995:Lang A:remoxipride:in:parkinson
20362-5664:1991:Gomez Mancilla B:effect:of:clonidine
20362-5664:1989:Wolters E:clozapine:an:antipsychotic
20362-5664:1987:Lang A:restless:legs:syndrome
20361-9230:1998:Loeffler D:altered:guanosine:and
20360-4012:1991:Tatton W:rescue:of:dying
20360-4012:1990:Peppard R:cortical:glucose:metabolism
20340-6717:2008:Destefano A:replication:of:association
20340-5354:2008:Lozano A:deep:brain:stimulation
20340-0131:2004:Beuter A:effect:of:chronic
20317-1671:2013:Zeiler F:subthalamic:nucleus:deep
20317-1671:2012:Salat Foix D:increased:intestinal:permeability
20317-1671:2012:Nelson A:dopamine:alters:tactile
20317-1671:2012:Elahi B:n:methyl:d
20317-1671:2011:Noreau A:glucocerebrosidase:mutations:in
20317-1671:2011:Auclair Ouellet N:transient:executive:dysfunction
20317-1671:2010:Wiltshire K:corpus:callosum:and
20317-1671:2010:Parent M:substantia:nigra:and
20317-1671:2010:Bharmal A:outcomes:of:patients
20317-1671:2008:Zadikoff C:pergolide:associated:cardiac
20317-1671:2008:Mendonca D:tasks:of:attention
20317-1671:2007:Yiannakoulias N:parkinson:s:disease
20317-1671:2007:Grimes D:lrrk:screening:in
20317-1671:2007:Dupre N:lrrk:is:not
20317-1671:2007:De Bie R:clinical:practice:regarding
20317-1671:2007:Camicioli R:clinical:trials:in
20317-1671:2007:Acharya H:axial:signs:and
20317-1671:2006:Zadikoff C:cardiac:valvulopathy:associated
20317-1671:2006:Scozzafava J:valvular:heart:disease
20317-1671:2005:Lang A:progress:in:clinical
20317-1671:2005:Han F:neurofilament:m:gene
20317-1671:2003:Martin W:treatment:of:parkinson
20317-1671:2003:Blanchet P:the:fluctuating:parkinsonian
20317-1671:2002:Parent A:jules:bernard:luys
20317-1671:2002:Jenkins M:hemiparkinsonism:somatic:hemiatrophy
20317-1671:2002:Guttman M:parkinsonism:in:ontario
20317-1671:2000:Honey C:a:prospective:randomized
20317-1671:1999:Stoessl A:etiology:of:parkinson
20317-1671:1999:Stoessl A:differential:diagnosis:of
20317-1671:1999:Rivest J:comt:inhibitors:in
20317-1671:1999:Honey C:new:developments:in
20317-1671:1999:Hobson D:ropinirole:and:pramipexole
20317-1671:1999:Guttman M:parkinson:s:disease
20317-1671:1999:Grimes D:treatment:of:early
20317-1671:1999:Blanchet P:rationale:for:use
20317-1671:1998:Martin W:increased:basal:ganglia
20317-1671:1998:Galvez Jimenez N:pallidal:stimulation:in
20317-1671:1997:Strafella A:pallidotomy:increases:cortical
20317-1671:1997:Paquet N:responses:to:dynamic
20317-1671:1997:Mehta V:neural:transplantation:in
20317-1671:1996:Galvez Jimenez N:perioperative:problems:in
20317-1671:1996:Charbonneau D:impaired:incentive:learning
20317-1671:1996:Blanchet P:risk:factors:for
20317-1671:1995:Chaturvedi S:environmental:exposures:in
20317-1671:1993:Borrett D:neural:networks:and
20317-1671:1992:Vezina P:deprenyl:in:parkinson
20317-1671:1992:Tatton W:interactions:between:mptp
20317-1671:1992:Stoessl A:prevention:and:management
20317-1671:1992:Snow B:positron:emission:tomography
20317-1671:1992:Robertson H:synergistic:interactions:of
20317-1671:1992:Rajput A:frequency:and:cause
20317-1671:1992:Mohr E:neuropsychological:and:glucose
20317-1671:1992:King D:the:place:of
20317-1671:1992:Eisen A:amyotrophic:lateral:sclerosis
20317-1671:1992:Beuter A:the:organization:of
20317-1671:1991:Semchuk K:parkinson:s:disease
20317-1671:1991:Rajput A:accuracy:of:clinical
20317-1671:1991:Poirier J:environment:genetics:and
20317-1671:1991:Kofman O:deprenyl:protective:vs
20317-1671:1991:Furtado J:mptp:induced:neurotoxicity
20317-1671:1990:Ross R:drug:induced:parkinsonism
20317-1671:1990:Lang A:cqa:in:parkinson
20317-1671:1989:Uitti R:regional:metal:concentrations
20317-1671:1989:Guttman M:pet:studies:of
20317-1671:1988:Taylor A:idiopathic:parkinson:s
20317-1671:1988:Riopelle R:adrenal:medulla:autografts
20317-1671:1988:Hurwitz T:treatment:of:dopaminomimetic
20317-1671:1988:Calne D:late:progression:of
20317-1671:1987:Libman I:a:comparison:of
20317-1671:1987:Kimura D:attentional:and:perseverative
20317-1671:1987:Calne S:familial:parkinson:s
20317-1671:1987:Barbeau A:ecogenetics:of:parkinson
20317-1671:1986:Rajput A:early:onset:parkinson
20315-162X:1998:Uhrin Z:rheumatoid:like:deformities
20306-9877:1992:Rathbone M:purinergic:stimulation:of
20306-9877:1992:Parkinson D:concussion:is:completely
20306-5251:1990:Campbell N:sinemet:ferrous:sulphate
20306-4522:2013:Lee D:reaching:to:proprioceptively
20306-4522:2011:Wichmann T:pathological:basal:ganglia
20306-4522:2011:Paquette C:walking:in:circles
20306-4522:2009:Palmer S:levodopa:sensitive:dynamic
20306-4522:2009:Mongeon D:impact:of:parkinson
20306-4522:2008:Lai Y:neurotoxic:lesions:at
20306-4522:2007:Lewis M:task:specific:influences
20306-4522:2006:Rasouli G:fractal:characteristics:of
20306-4522:2005:Rafuse V:neuroprotective:properties:of

Manipulations en shell (Unix/Dilib)

HfdCat /applis/lorexplor/Wicri/Amerique/Canada/explor/ParkinsonCanada.storage/ParkisonCanadaV1/Data/Main/Merge/Idat.i.hfd| SxmlCut idx/l | grep ...
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022